Follow
Karin van Garderen
Karin van Garderen
PhD student, Erasmus MC
Verified email at erasmusmc.nl
Title
Cited by
Cited by
Year
Towards continuous learning for glioma segmentation with elastic weight consolidation
K van Garderen, S van der Voort, F Incekara, M Smits, S Klein
arXiv preprint arXiv:1909.11479, 2019
182019
The effect of preprocessing on convolutional neural networks for medical image segmentation
KB De Raad, KA van Garderen, M Smits, SR van der Voort, F Incekara, ...
2021 IEEE 18th International Symposium on Biomedical Imaging (ISBI), 655-658, 2021
172021
Multi-modal segmentation with missing MR sequences using pre-trained fusion networks
K van Garderen, M Smits, S Klein
Domain Adaptation and Representation Transfer and Medical Image Learning …, 2019
122019
Effect of applying leakage correction on rcbv measurement derived from dsc-mri in enhancing and nonenhancing glioma
F Arzanforoosh, PL Croal, KA van Garderen, M Smits, MA Chappell, ...
Frontiers in Oncology 11, 648528, 2021
72021
EASE: clinical implementation of automated tumor segmentation and volume quantification for adult low-grade glioma
KA van Garderen, SR van der Voort, A Versteeg, M Koek, A Gutierrez, ...
Frontiers in Medicine 8, 738425, 2021
52021
OS07. 8. A Prognosis in IDH-mutant glioma: the role of extent-of-resection, age and tumor grade
T Van der Vaart, MMJ Wijnenga, KA van Garderen, H Dubbink, PJ French, ...
Neuro-oncology 24 (Suppl 2), ii17, 2022
22022
Active learning for overlay prediction in semi-conductor manufacturing
K van Garderen
22018
Association of pre-radiotherapy tumour burden and overall survival in newly diagnosed glioblastoma adjusted for MGMT promoter methylation status
A Alafandi, KA van Garderen, S Klein, SR van der Voort, D Rizopoulos, ...
European Journal of Cancer 188, 122-130, 2023
12023
Pre-contrast MAGiC in treated gliomas: a pilot study of quantitative MRI
L Nunez-Gonzalez, KA van Garderen, M Smits, J Jaspers, AM Romero, ...
Scientific Reports 12 (1), 21820, 2022
12022
Evaluating glioma growth predictions as a forward ranking problem
KA van Garderen, SR van der Voort, MMJ Wijnenga, F Incekara, ...
International MICCAI Brainlesion Workshop, 100-111, 2021
12021
OS06. 6. A FLAIR-SIGNAL INTENSITY CHANGE AS A PREDICTOR OF PROGRESSIVE GLIOBLASTOMA IN THE EORTC CENTRIC AND CORE STUDIES
CM Flies, M Friedrich, P Lohmann, K van Garderen, M Smits, JC Tonn, ...
Neuro-Oncology 25 (Supplement_2), ii17-ii18, 2023
2023
Evaluating the predictive value of glioma growth models for low-grade glioma after tumor resection
KA van Garderen, SR van der Voort, MMJ Wijnenga, F Incekara, ...
IEEE Transactions on Medical Imaging, 2023
2023
Deep learning-based group-wise registration for longitudinal MRI analysis in glioma
CC Hammecher, K van Garderen, M Smits, P Wesseling, B Westerman, ...
arXiv preprint arXiv:2306.10611, 2023
2023
Deep learning-based group-wise registration for longitudinal MRI analysis in glioma
C Chinea Hammecher, K van Garderen, M Smits, P Wesseling, ...
arXiv e-prints, arXiv: 2306.10611, 2023
2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort
KA van Garderen, WR Vallentgoed, A Lavrova, JM Niers, WWJ de Leng, ...
Neuro-Oncology Advances 5 (1), vdad149, 2023
2023
P07. 11. A Impact of awake craniotomy on extent-of-resection and performance in glioma: a retrospective, propensity-score matched cohort study
SJP Schnitzler, T van der Vaart, K van Garderen, MJ van den Bent, ...
Neuro-Oncology 24 (Suppl 2), ii42, 2022
2022
P17. 19. B Incidence of treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma treated with cilengitide (EORTC 26071-CENTRIC study …
CM Flies, M Friedrich, P Lohmann, K van Garderen, M Smits, JC Tonn, ...
Neuro-Oncology 24 (Supplement_2), ii93-ii93, 2022
2022
OS08. 1. A Integrative molecular analysis of matched primary and recurrent IDH-mutant astrocytoma; an update from the GLASS-NL consortium
WR Vallentgoed, Y Hoogstrate, E van Dijk, K van Garderen, A Niers, ...
Neuro-Oncology 24 (Supplement_2), ii18-ii18, 2022
2022
P05.04.A Disconcordance between different molecular methods to assess homozygous deletion of theCDKN2A/B locus in IDH-mutant astrocytomas
W Vallentgoed, E van Dijk, MJ van den Bent, K Draaisma, P van Eijk, ...
Neuro-Oncology 24 (Supplement_2), ii37-ii37, 2022
2022
Methylation analysis of matched primary and recurrent IDH-mutant astrocytoma; an update from the GLASS-NL consortium
WR Vallentgoed, A Niers, K van Garderen, M Bent, E van Dijk, ...
Cancer Research 82 (12_Supplement), 4020-4020, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20